Brivudin induced delirium: a case report
Yükleniyor...
Dosyalar
Tarih
2012
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Maney Publishing
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Brivudin is an oral antiviral agent used to treat herpes zoster infections. Common side effects of brivudin include nausea and headache. This report describes delirium in a patient who used brivudin for herpes zoster treatment, which consequently remitted after drug cessation on the fourth day of medication use. To our knowledge, no such side effect has been reported to date. However, it is important that clinicians who prescribe brivudin are aware that treatment cessation is likely to result in total clinical recovery.
Açıklama
Saritas, Ayhan/0000-0002-4302-1093; Saritas, Ayhan/0000-0002-4302-1093
WOS: 000307013400010
PubMed: 23040689
WOS: 000307013400010
PubMed: 23040689
Anahtar Kelimeler
Brivudin, Delirium
Kaynak
Journal Of Chemotherapy
WoS Q Değeri
Q4
Scopus Q Değeri
Q3
Cilt
24
Sayı
4
